<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1758">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04622748</url>
  </required_header>
  <id_info>
    <org_study_id>NIDD-2020-Neurocognition</org_study_id>
    <nct_id>NCT04622748</nct_id>
  </id_info>
  <brief_title>Neurocognitive Functions of Recovered COVID-19 Patients</brief_title>
  <official_title>An Investigation of Neurocognitive Functions and the Influencing Factors in Recovered Patients With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Drug Dependence, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University Sixth Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Wuchang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute on Drug Dependence, China</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is carried on in Wuchang Hospital in Wuhan, China. The investigators plan to&#xD;
      recruit 80 patients with COVID-19 and 80 matched healthy control. Using the design of&#xD;
      case-control study, the study aims to assess the neurocognitive functions such as executive&#xD;
      function and attentional bias in recovered patients with COVID-19 under normal and stress&#xD;
      conditions, and to analyze the influencing factors of neurocognitive functions, such as&#xD;
      mental health conditions, inflammation indicators and cardiopulmonary function.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2020</start_date>
  <completion_date type="Anticipated">December 10, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>working memory</measure>
    <time_frame>10 minutes</time_frame>
    <description>assessed by the n-back task, including 0-back, 1-back and 2-back</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive flexibility</measure>
    <time_frame>3 minutes</time_frame>
    <description>assessed by the trail-making task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibitory control</measure>
    <time_frame>10 minutes</time_frame>
    <description>assessed by the stroop task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Attention Bias</measure>
    <time_frame>15 minutes</time_frame>
    <description>assessed by the dot-probe task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum TNFalpha</measure>
    <time_frame>1 day</time_frame>
    <description>Concentration of serum TNFalpha in ng/ml will be assessed by ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum IL-6</measure>
    <time_frame>1 day</time_frame>
    <description>Concentration of serum IL-6 in ng/ml will be assessed by ELISA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>1 day</time_frame>
    <description>hypersensitive C-reactive protein(hs-CRP) in mg/L will be assessed by Turbidimetric inhibition immuno assay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>3-5 minutes</time_frame>
    <description>assessed by Self-Rating Depression Scale, which is consist of 20 items scoring 1 to 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>3-5 minutes</time_frame>
    <description>assessed by Self-Rating Anxiety Scale, which is consist of 20 items scoring 1 to 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTSD</measure>
    <time_frame>3-5 minutes</time_frame>
    <description>assessed by PTSD Checklist for DSM-5 (PCL-5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>3-5 minutes</time_frame>
    <description>assessed by Pittsburgh sleep quality index (PSQI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General cognition</measure>
    <time_frame>8-10 minutes</time_frame>
    <description>assessed by Montreal - Cognitive Assessment (MoCA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary function 1</measure>
    <time_frame>15 minutes</time_frame>
    <description>maximal inspiration pressure（MIP), maximal expiration pressure（MEP）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary function 2</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessed by the 6-minutes' walk test</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Stress response indicator 1</measure>
    <time_frame>Saliva samples will be colleted before stress, 0 minutes and 10 minutes after stress.</time_frame>
    <description>concentration of saliva cortisol stress, assessed by ELISA</description>
  </other_outcome>
  <other_outcome>
    <measure>Stress response indicator 2</measure>
    <time_frame>Assessed before and 0 minute after stress</time_frame>
    <description>Hear rates</description>
  </other_outcome>
  <other_outcome>
    <measure>Stress response indicator 3</measure>
    <time_frame>Assessed before and 0 minute after stress</time_frame>
    <description>Blood pressure before stress and after stress</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Cognition</condition>
  <condition>Covid-19</condition>
  <arm_group>
    <arm_group_label>COVID-19</arm_group_label>
    <description>Recovered COVID-19 patients in Wuhan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <description>Uninfected people in Wuhan</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Trier Social Stress Test</intervention_name>
    <description>8-min oral calculation and 5-min speech</description>
    <arm_group_label>COVID-19</arm_group_label>
    <arm_group_label>Healthy Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Recovered COVID-19 patients and uninfected residents in Wuhan&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Recovered COVID-19 patients or uninfected residents in Wuhan, with an education level&#xD;
             above elementary school and are able to complete cognitive tasks;&#xD;
&#xD;
          -  Willing to participate in this study and sign informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with body temperature&gt; 38°C;&#xD;
&#xD;
          -  Subjects who are in menstruation and pregnancy;&#xD;
&#xD;
          -  Subjects suffering from cardiopulmonary diseases before the new coronary pneumonia&#xD;
             epidemic (such as heart disease, pulmonary hypertension, congestive heart failure,&#xD;
             etc.);&#xD;
&#xD;
          -  Subjects with severe disturbances in consciousness, cognitive dysfunction, mental&#xD;
             disorders, visual and hearing disorders, bone and joint diseases, etc.;&#xD;
&#xD;
          -  Subjects with abnormal immune system and severe organ dysfunction (heart, liver,&#xD;
             kidney, etc.);&#xD;
&#xD;
          -  Subjects who are unwilling to participate in this study and cannot complete all&#xD;
             surveys and cognitive function tests.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lin Lu, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>National Institute on Drug Dependence, Peking University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ping Wu, Dr.</last_name>
    <phone>861082802470</phone>
    <phone_ext>509</phone_ext>
    <email>wuping@bjmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wuhan Wuchang Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430063</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guofu Huang, Dr</last_name>
      <phone>8618162533930</phone>
      <email>94615617@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 6, 2020</study_first_submitted>
  <study_first_submitted_qc>November 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2020</study_first_posted>
  <last_update_submitted>November 8, 2020</last_update_submitted>
  <last_update_submitted_qc>November 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

